Experienced in Ocular Hypertension (OHT)

Dr. David S. Boyer

Family Medicine | General Practice
7243 Della Dr Fl 3, 
Orlando, FL 
Experienced in Ocular Hypertension (OHT)
7243 Della Dr Fl 3, 
Orlando, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Boyer is a primary care provider, practicing in Family Medicine and General Practice in Orlando, Florida. Dr. Boyer is rated as an Experienced provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are Diabetic Macular Edema (DME), Diabetic Retinopathy, Mesenteric Venous Thrombosis, Vitrectomy, and Trabeculectomy.

His clinical research consists of co-authoring 148 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Ocular Hypertension (OHT).

Specialties
Family Medicine
General Practice
Licenses
Family Medicine in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

7243 Della Dr Fl 3, Orlando, FL 32819

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2/3 Double-Masked, Randomized, 2 Stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema
A Phase 2/3 Double-Masked, Randomized, 2 Stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema
Enrollment Status: Active_not_recruiting
Publish Date: October 02, 2025
Intervention Type: Drug
Study Drug: OCS-01 (Dexamethasone)
Study Phase: Phase 2/Phase 3
Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)
Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)
Enrollment Status: Active_not_recruiting
Publish Date: August 03, 2025
Intervention Type: Biological
Study Drug: OpRegen
Study Phase: Phase 1/Phase 2
Phase 1, Open-Label Safety and Pharmacodynamic Study of RV001, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist, Administered by Intravenous (IV) Infusion in Patients With Diabetic Macular Edema (DME)
Phase 1, Open-Label Safety and Pharmacodynamic Study of RV001, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist, Administered by Intravenous (IV) Infusion in Patients With Diabetic Macular Edema (DME)
Enrollment Status: Completed
Publish Date: June 25, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Prospective, Multicenter, Randomized, Study of the Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP)
A Prospective, Multicenter, Randomized, Study of the Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP)
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Other, Biological
Study Drug: Human retinal progenitor cells
Study Phase: Phase 2
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2021
Intervention Type: Device
Study Phase: Not Applicable
An Exploratory, Multi-Center, Randomized, Single-Masked Study Evaluating the Effect of KPI-121 on Intraretinal or Subretinal Fluid Secondary to Retinal Vein Occlusion or Diabetic Macular Edema
An Exploratory, Multi-Center, Randomized, Single-Masked Study Evaluating the Effect of KPI-121 on Intraretinal or Subretinal Fluid Secondary to Retinal Vein Occlusion or Diabetic Macular Edema
Enrollment Status: Completed
Publish Date: December 10, 2020
Intervention Type: Drug
Study Phase: Not Applicable
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Enrollment Status: Completed
Publish Date: April 28, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

148 Total Publications

RWC Update: Photobiomodulation for Non-Neovascular AMD; High Definition TRD with NGENUITY 1.5; Retinopathy of Prematurity.
RWC Update: Photobiomodulation for Non-Neovascular AMD; High Definition TRD with NGENUITY 1.5; Retinopathy of Prematurity.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: September 17, 2025
Similar Doctors
Experienced in Ocular Hypertension (OHT)
Dr. Harry G. Blackstone
Family Medicine
Experienced in Ocular Hypertension (OHT)
Dr. Harry G. Blackstone
Family Medicine

Zephyrhills Family Practice And Geriatric Care LLC

7213 Green Slope Dr, 
Zephyrhills, FL 
 (45.7 miles away)
813-715-0165
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Harry Blackstone is a primary care provider, practicing in Family Medicine in Zephyrhills, Florida. Dr. Blackstone is rated as a Distinguished provider by MediFind in the treatment of Ocular Hypertension (OHT). His top areas of expertise are High Cholesterol, Familial Hypertension, Hypothyroidism, and Obesity in Children. Dr. Blackstone is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boyer's expertise for a condition
ConditionClose
View All 50 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile